Found 64 events where Sex is Female and Vaccine is HPV4 and Patient Died

VAERS ID: 282372   Vaccinated: 2007-06-01 Age: 17.0   Onset: 2007-06-01, Days after vaccination: 0 Gender: Female   Submitted: 2007-06-19, Days after onset: 18 Location:    Entered: 2007-06-20, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: Dental operation CDC 'Split Type': WAES0706USA02451
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   0 UN UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Autopsy, Loss of consciousness, Resuscitation, Sudden death Write-up: Information has been received from a gynecologist who was informed of the case from another gynecologist concerning a 17 year old female who in June 2007 (week 23), was vaccinated with a first dose of Gardasil (lot number, injection site and route not reported). During the evening of the same day, the patient was found unconscious (lifeless) by the mother. Resuscitation was performed by the emergency physician but was unsuccessful. The patient subsequently died. The cause of death was sudden death. It was noted that the patient had a dental surgery the day before she was vaccinated. An autopsy was done. The results were not known. Other business partner numbers include E2007-03769. Additional information has been requested.
VAERS ID: 299377   Vaccinated: 2007-09-19 Age: 19.0   Onset: 2007-10-05, Days after vaccination: 16 Gender: Female   Submitted: 2007-12-11, Days after onset: 67 Location:    Entered: 2007-12-12, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 2007-10-12    Days after onset: 7 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: None CDC 'Split Type': WAES0712USA01347
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC. 1475F 0 UN UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Bronchitis, Death, Diarrhoea, Photophobia Write-up: Information has been received from a gynecologist concerning a 19 year old female with no previous medical history reported, who on 19-SEP-2007 was vaccinated (route and site not reported) with the 1st dose of Gardasil (Batch# NF37120, lot#1475F). On the morning of 12-OCT-2007, the patient was found dead in her bed. One week prior to death the female suffered from diarrhea, treatment without antibiotics. The patient also developed light sensitivity. The evening before the patient died she was out with a girlfriend until 3:00 am in the morning. The reporting physician excluded any drug misuse, as she knew the female as a sportive young woman. Contraception was stopped 3 months before vaccination. No reason for the death was detected in autopsy. The only finding in the autopsy was mild bronchitis and mucus. The reporting physician excluded any connection between vaccination and death. Other business partners numbers include E2007-08849(0). Additional information is not expected.
VAERS ID: 317695   Vaccinated: 2008-04-12 Age: 42.0   Onset: 2008-04-14, Days after vaccination: 2 Gender: Female   Submitted: 2008-06-26, Days after onset: 73 Location:    Entered: 2008-06-27, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: Unknown CDC 'Split Type': WAES0806MYS00011
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   0 UN UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Abdominal pain, Death, Haemorrhage, Inappropriate schedule of drug administration Write-up: Information has been received from a health professional concerning a 42 year old female who on 12 Apr 2008 was vaccinated with GARDASIL. Prior to the vaccination, the patient was reported looking weak and lost weight. On 14 Apr 2008, the patient returned to the clinic and complained of abdominal pain and bleeding. The patient was treated with painkillers for abdominal pain and advised to return if pain persists. The patient never came back. The second dose was due on 12 Jun 2008 but the patient did not turn up. On 14 Jun 2008, the clinic was informed that the patient had died. The cause of death was unknown. The reporter felt that abdominal pain, bleeding and death were not related to therapy with GARDASIL. No further information is available.
VAERS ID: 318244   Vaccinated: 0000-00-00 Age: 20.0   Onset: 0000-00-00 Gender: Female   Submitted: 2008-07-03 Location:    Entered: 2008-07-07, Days after submission: 4	Life Threatening Illness? No Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: None CDC 'Split Type': WAES0806USA09042
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   0 UN UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Death, Malaise, Pulmonary embolism Write-up: Information has been received from a physician concerning a 20 year old female with no relevant medical history reported who was vaccinated with a first dose of GARDASIL on an unspecified date. Subsequently, exact onset not reported, the patient felt unwell. About 6 weeks post vaccination, she experienced pulmonary embolism with fatal outcome. An autopsy is scheduled. Other business partner numbers included: E2008-05832. Additional information has been requested.
VAERS ID: 335270   Vaccinated: 2008-04-21 Age: 18.0   Onset: 2008-07-16, Days after vaccination: 86 Gender: Female   Submitted: 2008-12-12, Days after onset: 149 Location:    Entered: 2008-12-15, Days after submission: 3	Life Threatening Illness? No Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Pollen allergy; Allergic asthma; Overweight Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: KESTINE; NASACORT; SERETIDE; albuterol Preexisting Conditions: CDC 'Split Type': WAES0812USA02421
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   1 IM UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Autopsy, Death, Headache, No reaction on previous exposure to drug, Pain, Ruptured cerebral aneurysm Write-up: Information has been received from a general practitioner concerning an 18 year old female with pollen allergy, allergic asthma and who was overweight, with a family history of the mother having multiple sclerosis, who on 12-MAR-2008 was vaccinated with the first dose of GARDASIL, lot # not reported, which was well tolerated. It was reported that the second dose of GARDASIL, lot # not reported, was given intramuscularly (IM) to the right deltoid on 21-APR-2008. Concomitant therapy included SERETIDE, albuterol, NASACORT and KESTINE. There was no contraceptive use. On 16-JUL-2008 the patient experienced sudden brutal cephalgia and then she suffered from a pain evocating an aneurysm during rupture. The patient suddenly died in spite of resuscitation technique performed by the agency which evoked a ruptured aneurysm. An autopsy was on-going and the results would be provided. As to the reporter there may not be any link between adverse effect and vaccination. The reported cause of death by the ageny was ruptured cerebral aneurysm, but it had not been confirmed yet by the results of the autopsy which were still pending. Additional information has been requested. Other business partner numbers include E2008-11575.
VAERS ID: 338452   Vaccinated: 2008-10-20 Age: 15.0   Onset: 2008-12-30, Days after vaccination: 71 Gender: Female   Submitted: 2009-01-27, Days after onset: 28 Location:    Entered: 2009-01-28, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 2008-12-30    Days after onset: 0 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Preexisting Conditions: Unknown CDC 'Split Type': WAES0901USA03040
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC. 1316U 1 IM LA
Administered by: Unknown     Purchased by: Unknown Symptoms: Autopsy, Death Write-up: Information has been received from a health authority (reference # PEI2009000661) concerning a 15 year old female who on 20-OCT-2008 was vaccinated with the first dose of GARDASIL, lot #1427U (batch #NH15200) IM into the left upper arm. No information regarding toleration was given. On 29-DEC-2008, the patient was vaccinated with a second dose of GARDASIL, lot #1316U (batch #NH45640) IM into the left upper arm. On 30-DEC-2008 the patient died. According to the preliminary report, the autopsy showed no acute or chronic organic disease. The possibility of carbon monoxide intoxication was not yet ruled out. Investigation by public prosecution is ongoing. Lot checks have been requested. Other business partner numbers included: E2009-00404. Additional information has been requested.
VAERS ID: 338561   Vaccinated: 2008-12-27 Age: 20.0   Onset: 2009-01-01, Days after vaccination: 5 Gender: Female   Submitted: 2009-01-28, Days after onset: 27 Location:    Entered: 2009-01-29, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? Yes, 0 days     Extended hospital stay? No Current Illness: Asthenia; Anxiety; Overwork; Psychological disorder NOS Diagnostic Lab Data: electrocardiogram, 03Jan09, arrhythmia with atrial fibrillation; X-ray, 03Jan09, pneumopathy of right middle pulmonary lobe and septal hypokinesia; body temp, 01?Jan09, 38 C; WBC count, 03Jan09, 12.4.103/mm3; body temp, 03Jan09, 33.7 C; blo Previous Vaccinations: Other Medications: BUSPAR; LEXOMIL; hormonal contraceptives (unspecified); magnesium (unspecified) (+) pyridoxine hydrochloride Preexisting Conditions: Cardiac Murmur CDC 'Split Type': WAES0901USA03398
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   1 UN UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Arrhythmia, Atrial fibrillation, Autopsy, Blood glucose increased, Body temperature decreased, Body temperature increased, Cyanosis, Death, Drug screen negative, Dyspnoea, Electrocardiogram abnormal, Hyperthermia, Hypothermia, Intensive care, Laboratory test normal, Leukocytosis, Lung disorder, Malaise, Multi-organ failure, Mydriasis, Tachycardia, Tremor, Ventricular hypokinesia, White blood cell count increased, X-ray abnormal Write-up: Information has been received from a specialist and from the health authority, concerning a 20 year old female with asthenia, anxiety/overwork syndrome and psychologic fragility since May 2008 and a history of cardiac murmur during childhood, who in OCT-2008 was vaccinated with the first dose of GARDASIL. The patient had no adverse effects after this dose. Concomitant therapy included BUSPAR, LEXOMIL, magnesium (unspecified) (+) pyridoxine hydrochloride and hormonal contraceptives (unspecified). On 27-DEC-2008 the patient was vaccinated with the second dose of GARDASIL, batch number not reported. It was reported that 3 days after the second dose of GARDASIL, i.e. in JAN-2009 the patient presented with hyperthermia at 38 C associated with breathlessness. After a malaise during shopping on 01-JAN-2009 the patient consulted her general practitioner; she had tremor and tachycardia. Blood analysis was performed on 03-JAN-2009 and revealed a slight hyperleukocytosis (12.4 103/mm3). By the evening on 03-JAN-2009 the patient presented with a malaise again but with no dyspnea and after taking BUSPAR. 2 hours later the intervention of EMUR (emergency medical mobile unit) could lead to recuperate a sinusal rhythm. Continuous arrhythmia with atrial fibrillation was diagnosed. The patient was transferred to medical intensive care service: she presented with bilateral mydriasis, hypothermia at 33.7 C, the result of measure of sugar in her blood was increased at 3.18 and she had cyanosis of face, ears, and extremities. Radiological examinations revealed a pneumopathy of the right middle pulmonary lobe and septal hypokinesia with paradoxical septal. There was no cocaine and no benzodiazepines. The patient presented with multiorgan failure under high dose of amines and then she dies in spite of the cardiopulmonary by-pass and extra corporeal oxygenation assistance. An autopsy was performed (unspecified date) and found no cause of death, also reported as information on autopsy was still awaited. Other business partner numbers incl
VAERS ID: 341030   Vaccinated: 0000-00-00 Age: 14.0   Onset: 0000-00-00 Gender: Female   Submitted: 2009-03-03 Location:    Entered: 2009-03-04, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: Unknown CDC 'Split Type': WAES0902CAN00119
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.     UN UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Death Write-up: Information has been received from an Agency concerning a 14 year old female who was vaccinated with GARDASIL, lot # not available. Subsequently the patient died. The cause of death was unknown. Additional information has been requested.
VAERS ID: 343612   Vaccinated: 2008-11-01 Age: 23.0   Onset: 2008-11-26, Days after vaccination: 25 Gender: Female   Submitted: 2009-04-06, Days after onset: 130 Location:    Entered: 2009-04-07, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 2008-11-26    Days after onset: 0 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Contraception Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: hormonal contraceptives (unspecified) Preexisting Conditions: CDC 'Split Type': WAES0903AUS00084
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.     UN UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Autopsy, Hypertrophic cardiomyopathy, Sudden death Write-up: Information has been received from a physician, via agency, as part of a business agreement (manufacturer control No. GARD 2009 03 27 LS2), concerning a 23 year old female who in November 2008 was vaccinated with GARDASIL. Concomitant therapy included hormonal contraceptives (unspecified) in the form of a vaginal contraceptive ring. On 26-NOV-2008, a few days after vaccination with GARDASIL the patient died suddenly. The cause of death was attributed to hypertrophic cardiomyopathy. It was reported that an autopsy was performed (report not provided). A few days prior to her death, the patient had visited her physician to discuss contraception. She was not taking any other drugs other than contraception and had no underlying conditions or hereditary conditions. The reporter considered that hypertrophic cardiomyopathy was not related to therapy with GARDASIL, stating "I'm sure it was not directly related". Additional information has been requested.
VAERS ID: 350228   Vaccinated: 2009-06-09 Age: 14.0   Onset: 2009-06-12, Days after vaccination: 3 Gender: Female   Submitted: 2009-06-25, Days after onset: 13 Location:    Entered: 2009-06-26, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 2009-06-12    Days after onset: 0 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: hormonal contraceptives (unspecified) Preexisting Conditions: Asthma bronchial CDC 'Split Type': WAES0906USA04039
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC. 1477U 0 IM UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Asthma, Autopsy, Condition aggravated, Death Write-up: Information has been received from a gynaecologist concerning an approximate 14 year old female patient with a history of bronchial asthma, who was vaccinated with a first dose of GARDASIL (lot # not reported) IM into the upper arm on 09-JUN-2009. On 12-JUN-2009, the patient experienced an asthmatic attack of which she died. The patient had no long-term medication for the asthma but only on occasion. Concomitant medication included hormonal contraceptives (unspecified). Reportedly, an autopsy was performed. The result is not yet known. A causal relation to the GARDASIL vaccine was considered unlikely by the vaccinating physician. Follow-up information received on 22-JUN-2009: Exact birth date, initials, height (158 cm) and weight (50 kg) as well as lot # 1477U, batch # NH25390 were provided. Following information gathered by phone from the reporting physician, the girl experienced the asthmatic attack at home and an emergency doctor was called. He was not able to arrest the attack and resuscitation was unsuccessful. Other business partner's numbers included: E2009-05085.
VAERS ID: 372910   Vaccinated: 2009-03-17 Age: 18.0   Onset: 2009-09-22, Days after vaccination: 189 Gender: Female   Submitted: 2009-12-10, Days after onset: 79 Location:    Entered: 2009-12-11, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 2009-09-22    Days after onset: 0 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Herpes virus infection Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: CDC 'Split Type': WAES0912USA00953
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC. 1283U 2 IM UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Sudden death Write-up: Information has been received from the agency via Case Line listing via CSL, as part of a business agreement, concerning an 18 year old female patient with disseminated herpes viral disease who on 17-MAR-2009 was vaccinated with the third dose of GARDASIL (batch #NJ11440, lot# 1283U). The second suspect therapy included DEPO-PROVERA which was administered IM, 600 mg yearly, from 2007 October to 2009 January. On 22-SEP-2009 the patient developed sudden death (severe). It was unknown if the patient sought medical attention. A lot check has been initiated. No further information is available.
VAERS ID: 375036   Vaccinated: 2007-05-22 Age: 17.0   Onset: 2007-07-11, Days after vaccination: 50 Gender: Female   Submitted: 2009-12-23, Days after onset: 896 Location:    Entered: 2009-12-24, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 2007-07-15    Days after onset: 4 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? Yes, 0 days     Extended hospital stay? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: VALETTE Preexisting Conditions: none CDC 'Split Type': WAES0912USA02946
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC. 0859F 0 IM UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Autopsy, Death, Osteitis Write-up: Information has been received from a physician concerning a previous healthy 17 year old female patient with no relevant medical history who on 22-MAY was vaccinated intramuscularly with her first dose of GARDASIL (Lot # 654740/0859F) (Batch # NE29660) (Injection site was not reported). Concomitant therapy included VALETTE. On 11-JUL-2007 the reporter was informed by the patient's mother that her daughter was hospitalized due to bone inflammation. On 15-JUL-2007, approximately 7 weeks post vaccination, the patient died of unknown cause. An autopsy was carried out, but the result was not known to the reporter up to the time of reporting. A lot check has been initiated. Other business partner numbers include E2009-11667. Additional information has been requested.
VAERS ID: 379570   Vaccinated: 2009-07-20 Age: 12.0   Onset: 2009-09-06, Days after vaccination: 48 Gender: Female   Submitted: 2010-02-04, Days after onset: 151 Location:    Entered: 2010-02-05, Days after submission: 1	Life Threatening Illness? Yes Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: Unknown CDC 'Split Type': WAES1001USA03763
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   0 IM UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Death, Drowning, Fall Write-up: Information has been received from from a physician concerning a 12 year old school going girl of class eight of a village. On 20-JUL-2009, the patient received first dose of GARDASIL in the school. During the process of community mobilization for second dose of GARDASIL, the female health worker was informed that on 06-SEP-2009, the patient accidentally fell in open well (granite quarry filled with water), drowned and expired. This event occurred 49 days of receiving first dose of GARDASIL. The female health worker informed the Medical Officer in-charge, which was then communicated to District Immunization Officer. The medical officer in-charge investigated the death and completed first information report and determined that death was not related to the vaccine.
VAERS ID: 379874   Vaccinated: 2009-07-16 Age: 14.0   Onset: 2009-08-29, Days after vaccination: 44 Gender: Female   Submitted: 2010-02-08, Days after onset: 163 Location:    Entered: 2010-02-09, Days after submission: 1	Life Threatening Illness? Yes Died? Yes    Date died: 2009-08-29    Days after onset: 0 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Preexisting Conditions: Unknown CDC 'Split Type': WAES1001USA03762
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   0 UN LA
Administered by: Unknown     Purchased by: Unknown Symptoms: Completed suicide, Death, Poisoning Write-up: Information has been received from a physician concerning a 14 year old school going girl (ID#: -3/09) who received the first dose of GARDASIL in left deltoid, on 16-JUL-2009. Concomitant therapy included indigo. During the process of community mobilization for second dose, the female health worker was informed that the patient committed suicide on 29-AUG-2009 by consuming insecticide. The postmortem was performed on 30-AUG-2009. This event occurred after 45 days of receiving first dose of GARDASIL. The female health worker informed the medical officer in charge, which was then communicated to Immunization Officer. The medical officer in charge investigated the death and completed first information report as per guidelines and determined the death was not related to the vaccine and so no further investigations were done. No further information is available.
VAERS ID: 379876   Vaccinated: 2009-07-19 Age: 13.0   Onset: 2010-01-21, Days after vaccination: 186 Gender: Female   Submitted: 2010-02-08, Days after onset: 18 Location:    Entered: 2010-02-09, Days after submission: 1	Life Threatening Illness? Yes Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? Yes, 0 days     Extended hospital stay? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: Unknown CDC 'Split Type': WAES1002USA00379
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   1 IM UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Completed suicide, General physical health deterioration, Poisoning deliberate Write-up: Information has been received from a physician concerning a 13 year old school going girl (ID#: -104/09) of class eight. On 19-JUL-2009, patient received first dose of GARDASIL left deltoid (lot#876, manufacturing date June 2008). Patient successfully completed her second dose on 13-OCT-2009. She was due with her third dose. On 21-JAN-2010, she was reported to have consumed poison around 9:00 am. She was taken to the area hospital and provided preliminary emergency treatment. She was provided DECADRON injection 2 cc, injection dopamine 1 amp. in 5% dextrose 10-12 drops/min, injection deriphylline I.V 8 hourly, injection diazepam 1 amp. IV, Ryle's tube aspiration and stomach wash. It was advised to record her temperature, pulse, respiration, and blood pressure half hourly and had oxygen inhalation. High risk consent was taken. As her condition started to deteriorate she was shifted to another hospital by '108 emergency service' for further evaluation and management. On the way to the hospital, it was reported to have expired around 2:00 pm on 21-JAN-2010. The hospital noted the case was "brought dead". The postmortem was performed on 22-JAN-2010 and the results are awaited. The medical officer in charge investigated the death and completed first information report and determined the death could be suicide (due to poison intake) and not related to the vaccine. This report was part of a post-marketing surveillance program.
VAERS ID: 380081   Vaccinated: 2009-07-17 Age: 13.0   Onset: 2009-08-08, Days after vaccination: 22 Gender: Female   Submitted: 2010-02-05, Days after onset: 181 Location:    Entered: 2010-02-12, Days after submission: 7	Life Threatening Illness? Yes Died? Yes    Date died: 2009-08-08    Days after onset: 0 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? Yes, 0 days     Extended hospital stay? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: RANTAC; acetaminophen, aminophylline; chloroquine Preexisting Conditions: Unknown CDC 'Split Type': WAES1001USA03765
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.     IM UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Coma, Death, Dyspnoea, Pyrexia Write-up: Information has been received from a physician concerning a 13 year old school girl studying in class nine of health center. On 17-JUL-2009, patient received first dose of GARDASIL left deltoid. Concomitant medications included chloroquine, RANTAC, paracetamol, "IV fluids RL" and aminophyline drip. During the process of community mobilization for second dose of GARDASIL the multipurpose health worker was informed that the patient developed fever on 01-AUG-2009 and was treated by local registered medical practitioner (RMP). The patient did not recover and was admitted to the hospital on 08-AUG-2009. On the same day, GENTAMYCIN was given. She developed dyspnoea and went into coma and so was referred and was shifted to another hospital where she expired on 08-AUG-2009 at around 9:00 pm. The cause of death was determined as "death due to viral fever". The information was provided from patient's maternal grandparents as she was staying with them. This event occurred after 23 days of receiving first dose of GARDASIL. The female health worker informed the medical officer in charge and he investigated the death and completed the first information report as per AEFI guidelines. The case sheet mentions as "pyrexia of unknown origin". This information was then communicated to district immunization officer, who determined that the death was not related to the vaccine and so a decision was taken to close the investigation.
VAERS ID: 384205   Vaccinated: 0000-00-00 Age: 13.0   Onset: 0000-00-00 Gender: Female   Submitted: 2010-04-02 Location: Unknown   Entered: 2010-04-05, Days after submission: 3	Life Threatening Illness? No Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: Unknown CDC 'Split Type': WAES1003USA04772
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   0 UN UN
Administered by: Other     Purchased by: Other Symptoms: Death, Headache, Vaccine positive rechallenge Write-up: Information has been received from a nurse practitioner concerning a 13 year old female patient who on unspecified dates was vaccinated with three doses of GARDASIL at the nurse practitioner's previous practice. The patient experienced headache after getting first and second dose of GARDASIL. The patient sought unspecified medical attention. After the third dose of GARDASIL the patient experienced headache and died on the same day. The cause of death was not reported. Additional information has been requested.
VAERS ID: 385303   Vaccinated: 0000-00-00 Age:    Onset: 2010-03-01 Gender: Female   Submitted: 2010-04-15, Days after onset: 44 Location: Unknown   Entered: 2010-04-16, Days after submission: 1	Life Threatening Illness? No Died? Yes    Date died: 2010-03-01    Days after onset: 0 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: Unknown CDC 'Split Type': WAES1004USA01848
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.   2 UN UN
Administered by: Other     Purchased by: Other Symptoms: Death Write-up: Information has been received from a Nurse at the physician's office who heard from another Nurse that a patient came in to the office to receive the third dose of GARDASIL and the friend of the patient told her not to get the third dose because she knew of another girl that received the third dose of GARDASIL and died "within the last month" (cause of death not reported). It was unknown if the patient sought medical attention. Attempts are being made to verify the existence of an identifiable patient. Additional information has been requested.
VAERS ID: 387160   Vaccinated: 0000-00-00 Age: 16.0   Onset: 0000-00-00 Gender: Female   Submitted: 2010-05-10 Location: Unknown   Entered: 2010-05-11, Days after submission: 1	Life Threatening Illness? Yes Died? Yes    Date died: 0000-00-00 Disability? No Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: Unknown CDC 'Split Type': WAES1005USA00536
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.     UN UN
Administered by: Other     Purchased by: Other Symptoms: Autopsy, Death, Headache Write-up: Information has been received from a physician who found out from another treating physician who was also the father of the patient, concerning a 16 year old female patient who on an unknown date, was vaccinated with a dose of GARDASIL. Subsequently the patient developed a severe headache. Then the patient went to sleep that night and passed away. The autopsy was performed which revealed no cause of death. It is unknown if the patient sought medical attention. Severe headache was considered to be immediately life-threatening. Additional information has been requested.
VAERS ID: 391439   Vaccinated: 0000-00-00 Age: 18.0   Onset: 0000-00-00 Gender: Female   Submitted: 2010-06-24 Location: Unknown   Entered: 2010-06-25, Days after submission: 1	Life Threatening Illness? Yes Died? Yes    Date died: 0000-00-00 Disability? Yes Recovered? No ER or Doctor Visit? No Hospitalized? No Current Illness: Diagnostic Lab Data: Unknown Previous Vaccinations: Other Medications: Unknown Preexisting Conditions: Convulsion CDC 'Split Type': WAES1006USA02143
Vaccination Manufacturer Lot Dose Route Site HPV4 MERCK & CO. INC.     UN UN
Administered by: Other     Purchased by: Other Symptoms: Condition aggravated, Convulsion, Death Write-up: Information has been received from a Registered Nurse concerning an 18 year old female patient with a history of seizures prior to GARDASIL, who on an unspecified date was vaccinated with a dose of GARDASIL. The nurse advised that the patient experienced seizure and subsequent death after receiving GARDASIL. It was not advised which injection in the series caused the adverse experience or how the injection was administered. The health care professional was contacted by telephone and call would not supply the following information: patient name, date of birth, dates of vaccination/therapy, dose number, lot number and date of event. Seizure was considered to be disabling and immediately life-threatening. Additional information has been requested.